What if you could control computers with just a thought? Precision Neuroscience is one of several companies working to make that a reality. Michael Mager is the co-founder and CEO of the brain-computer interface company whose technology aims to give patients with severe mobility issues new ways to interact with the digital world. How does Precision plan to offer brain implants to millions of people who could benefit from them? And how is the company competing with rivals like Synchron and Elon Musk’s Neuralink? Mager speaks to WSJ’s Christopher Mims and Tim Higgins on the latest episode of the Bold Names podcast.
Check Out Past Episodes:
Why Elon Musk’s Battery Guy Is Betting Big on Recycling
Venture Capitalist Sarah Guo’s Surprising Bet on Unsexy AI
Could Amazon’s Zoox Beat Tesla and Waymo in the Robotaxi Race?
Humanoid Robot Startups Are Hot. This AI Expert Cuts Through the Hype.
Let us know what you think of the show. Email us at
[email protected]
Sign up for the WSJ's free Technology newsletter.
Read Christopher Mims’s Keywords column.
Read Tim Higgins’s column.
Learn more about your ad choices. Visit megaphone.fm/adchoices
